Shanghai Kehua Bio-Engineering Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.01%

Shanghai Kehua Bio-Engineering Co Ltd (002022) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥305.66K

≈ $44.73K USD Cash + Short-term Investments

Total Assets

CN¥4.55 Billion

≈ $665.33 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2002–2025)

This chart shows how Shanghai Kehua Bio-Engineering Co Ltd's Asset Resilience Ratio has changed over time. Check 002022 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Kehua Bio-Engineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Kehua Bio-Engineering Co Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥305.66K	0.01%
Total Liquid Assets	CN¥305.66K	0.01%

Asset Resilience Insights

Limited Liquidity: Shanghai Kehua Bio-Engineering Co Ltd maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Kehua Bio-Engineering Co Ltd Industry Peers by Asset Resilience Ratio

Compare Shanghai Kehua Bio-Engineering Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Cochlear Ltd AU:COH	Medical Devices	9.76%
Novocure Ltd NASDAQ:NVCR	Medical Devices	43.72%
Sinocare Inc SHE:300298	Medical Devices	3.53%
L&C Bio Co. Ltd KQ:290650	Medical Devices	2.14%
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	Medical Devices	10.88%
Bactiguard Holding AB (publ) ST:BACTI-B	Medical Devices	8.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%

Annual Asset Resilience Ratio for Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)

The table below shows the annual Asset Resilience Ratio data for Shanghai Kehua Bio-Engineering Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.30%	CN¥60.36 Million ≈ $8.83 Million	CN¥4.64 Billion ≈ $679.19 Million	+1.29pp
2024-12-31	0.01%	CN¥293.59K ≈ $42.96K	CN¥5.24 Billion ≈ $766.21 Million	-4.65pp
2023-12-31	4.65%	CN¥316.77 Million ≈ $46.35 Million	CN¥6.81 Billion ≈ $996.19 Million	+4.63pp
2018-12-31	0.03%	CN¥962.53K ≈ $140.85K	CN¥3.50 Billion ≈ $512.71 Million	+0.01pp
2010-12-31	0.02%	CN¥234.08K ≈ $34.25K	CN¥1.09 Billion ≈ $159.05 Million	-0.02pp
2009-12-31	0.04%	CN¥363.28K ≈ $53.16K	CN¥925.84 Million ≈ $135.48 Million	-0.28pp
2006-12-31	0.32%	CN¥1.56 Million ≈ $228.10K	CN¥484.49 Million ≈ $70.90 Million	-4.11pp
2002-12-31	4.43%	CN¥10.00 Million ≈ $1.46 Million	CN¥225.50 Million ≈ $33.00 Million	--

pp = percentage points

About Shanghai Kehua Bio-Engineering Co Ltd

SHE:002022 China Medical Devices

Market Cap

$388.37 Million

CN¥2.65 Billion CNY

Market Cap Rank

#13462 Global

#3969 in China

Share Price

CN¥5.16

Change (1 day)

+1.38%

52-Week Range

CN¥4.58 - CN¥8.06

All Time High

CN¥29.42